Global and United States Rheumatoid Arthritis (RA) Drugs Market Report & Forecast 2022-2028

Publisher Name :
Date: 07-Jun-2022
No. of pages: 96
Inquire Before Buying

Rheumatoid Arthritis (RA) Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis (RA) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Rheumatoid Arthritis (RA) Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- NSAIDs

- Analgesic Drugs

- Corticosteroids

- DMARDs

- Biological Therapies

- JAK-inhibitors

Segment by Application

- Hospitals

- Clinics

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- AbbVie

- Roche

- Merck

- HEYL Chemisch-pharmazeutische Fabrik

- Johnson & Johnson

- Amgen, Inc.

- Pfizer

- Bristol-Myers Squibb

- UCB

- GSK

- Sanofi

- Abbott Laboratories

- Teva Pharmaceutical

Global and United States Rheumatoid Arthritis (RA) Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Rheumatoid Arthritis (RA) Drugs Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Rheumatoid Arthritis (RA) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size for the Year 2017-2028
1.2.2 Global Rheumatoid Arthritis (RA) Drugs Market Size for the Year 2017-2028
1.3 Rheumatoid Arthritis (RA) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Rheumatoid Arthritis (RA) Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Rheumatoid Arthritis (RA) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Rheumatoid Arthritis (RA) Drugs Market Dynamics
1.4.1 Rheumatoid Arthritis (RA) Drugs Industry Trends
1.4.2 Rheumatoid Arthritis (RA) Drugs Market Drivers
1.4.3 Rheumatoid Arthritis (RA) Drugs Market Challenges
1.4.4 Rheumatoid Arthritis (RA) Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Rheumatoid Arthritis (RA) Drugs by Type
2.1 Rheumatoid Arthritis (RA) Drugs Market Segment by Type
2.1.1 NSAIDs
2.1.2 Analgesic Drugs
2.1.3 Corticosteroids
2.1.4 DMARDs
2.1.5 Biological Therapies
2.1.6 JAK-inhibitors
2.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2028)
2.4 United States Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2028)
3 Rheumatoid Arthritis (RA) Drugs by Application
3.1 Rheumatoid Arthritis (RA) Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2028)
3.4 United States Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2028)
4 Global Rheumatoid Arthritis (RA) Drugs Competitor Landscape by Company
4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Company
4.1.1 Top Global Rheumatoid Arthritis (RA) Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue by Player (2017-2022)
4.2 Global Rheumatoid Arthritis (RA) Drugs Concentration Ratio (CR)
4.2.1 Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Rheumatoid Arthritis (RA) Drugs in 2021
4.2.3 Global Rheumatoid Arthritis (RA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rheumatoid Arthritis (RA) Drugs Headquarters, Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Rheumatoid Arthritis (RA) Drugs Headquarters and Area Served
4.3.2 Global Rheumatoid Arthritis (RA) Drugs Companies Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Rheumatoid Arthritis (RA) Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Rheumatoid Arthritis (RA) Drugs Market Size by Company
4.5.1 Top Rheumatoid Arthritis (RA) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rheumatoid Arthritis (RA) Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region
5.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (2017-2028)
5.2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region: 2017-2022
5.2.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Rheumatoid Arthritis (RA) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Rheumatoid Arthritis (RA) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Rheumatoid Arthritis (RA) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Details
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Introduction
7.1.4 AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.1.5 AbbVie Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Rheumatoid Arthritis (RA) Drugs Introduction
7.2.4 Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.2.5 Roche Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck Rheumatoid Arthritis (RA) Drugs Introduction
7.3.4 Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.3.5 Merck Recent Development
7.4 HEYL Chemisch-pharmazeutische Fabrik
7.4.1 HEYL Chemisch-pharmazeutische Fabrik Company Details
7.4.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
7.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Introduction
7.4.4 HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.4.5 HEYL Chemisch-pharmazeutische Fabrik Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Details
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Introduction
7.5.4 Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.5.5 Johnson & Johnson Recent Development
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Company Details
7.6.2 Amgen, Inc. Business Overview
7.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Introduction
7.6.4 Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.6.5 Amgen, Inc. Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Details
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Introduction
7.7.4 Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.7.5 Pfizer Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Introduction
7.8.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.8.5 Bristol-Myers Squibb Recent Development
7.9 UCB
7.9.1 UCB Company Details
7.9.2 UCB Business Overview
7.9.3 UCB Rheumatoid Arthritis (RA) Drugs Introduction
7.9.4 UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.9.5 UCB Recent Development
7.10 GSK
7.10.1 GSK Company Details
7.10.2 GSK Business Overview
7.10.3 GSK Rheumatoid Arthritis (RA) Drugs Introduction
7.10.4 GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.10.5 GSK Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Details
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Introduction
7.11.4 Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.11.5 Sanofi Recent Development
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Company Details
7.12.2 Abbott Laboratories Business Overview
7.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Introduction
7.12.4 Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.12.5 Abbott Laboratories Recent Development
7.13 Teva Pharmaceutical
7.13.1 Teva Pharmaceutical Company Details
7.13.2 Teva Pharmaceutical Business Overview
7.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Introduction
7.13.4 Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
7.13.5 Teva Pharmaceutical Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Rheumatoid Arthritis (RA) Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Rheumatoid Arthritis (RA) Drugs Market Trends
Table 3. Rheumatoid Arthritis (RA) Drugs Market Drivers
Table 4. Rheumatoid Arthritis (RA) Drugs Market Challenges
Table 5. Rheumatoid Arthritis (RA) Drugs Market Restraints
Table 6. Global Rheumatoid Arthritis (RA) Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Rheumatoid Arthritis (RA) Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Rheumatoid Arthritis (RA) Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Rheumatoid Arthritis (RA) Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Rheumatoid Arthritis (RA) Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Player, 2017-2022
Table 13. Global Rheumatoid Arthritis (RA) Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rheumatoid Arthritis (RA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis (RA) Drugs as of 2021)
Table 15. Top Players of Rheumatoid Arthritis (RA) Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Rheumatoid Arthritis (RA) Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Rheumatoid Arthritis (RA) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Rheumatoid Arthritis (RA) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Rheumatoid Arthritis (RA) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Rheumatoid Arthritis (RA) Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Rheumatoid Arthritis (RA) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Rheumatoid Arthritis (RA) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Rheumatoid Arthritis (RA) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Rheumatoid Arthritis (RA) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. AbbVie Company Details
Table 31. AbbVie Business Overview
Table 32. AbbVie Rheumatoid Arthritis (RA) Drugs Product
Table 33. AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 34. AbbVie Recent Development
Table 35. Roche Company Details
Table 36. Roche Business Overview
Table 37. Roche Rheumatoid Arthritis (RA) Drugs Product
Table 38. Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 39. Roche Recent Development
Table 40. Merck Company Details
Table 41. Merck Business Overview
Table 42. Merck Rheumatoid Arthritis (RA) Drugs Product
Table 43. Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 44. Merck Recent Development
Table 45. HEYL Chemisch-pharmazeutische Fabrik Company Details
Table 46. HEYL Chemisch-pharmazeutische Fabrik Business Overview
Table 47. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product
Table 48. HEYL Chemisch-pharmazeutische Fabrik Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 49. HEYL Chemisch-pharmazeutische Fabrik Recent Development
Table 50. Johnson & Johnson Company Details
Table 51. Johnson & Johnson Business Overview
Table 52. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product
Table 53. Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 54. Johnson & Johnson Recent Development
Table 55. Amgen, Inc. Company Details
Table 56. Amgen, Inc. Business Overview
Table 57. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product
Table 58. Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 59. Amgen, Inc. Recent Development
Table 60. Pfizer Company Details
Table 61. Pfizer Business Overview
Table 62. Pfizer Rheumatoid Arthritis (RA) Drugs Product
Table 63. Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 64. Pfizer Recent Development
Table 65. Bristol-Myers Squibb Company Details
Table 66. Bristol-Myers Squibb Business Overview
Table 67. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product
Table 68. Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 69. Bristol-Myers Squibb Recent Development
Table 70. UCB Company Details
Table 71. UCB Business Overview
Table 72. UCB Rheumatoid Arthritis (RA) Drugs Product
Table 73. UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 74. UCB Recent Development
Table 75. GSK Company Details
Table 76. GSK Business Overview
Table 77. GSK Rheumatoid Arthritis (RA) Drugs Product
Table 78. GSK Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 79. GSK Recent Development
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Rheumatoid Arthritis (RA) Drugs Product
Table 83. Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 84. Sanofi Recent Development
Table 85. Abbott Laboratories Company Details
Table 86. Abbott Laboratories Business Overview
Table 87. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product
Table 88. Abbott Laboratories Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 89. Abbott Laboratories Recent Development
Table 90. Teva Pharmaceutical Company Details
Table 91. Teva Pharmaceutical Business Overview
Table 92. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product
Table 93. Teva Pharmaceutical Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2022) & (US$ Million)
Table 94. Teva Pharmaceutical Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Rheumatoid Arthritis (RA) Drugs Product Picture
Figure 2. Global Rheumatoid Arthritis (RA) Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Rheumatoid Arthritis (RA) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Rheumatoid Arthritis (RA) Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Rheumatoid Arthritis (RA) Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Rheumatoid Arthritis (RA) Drugs Market Share in Global 2017-2028
Figure 7. Rheumatoid Arthritis (RA) Drugs Report Years Considered
Figure 8. Product Picture of NSAIDs
Figure 9. Product Picture of Analgesic Drugs
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of DMARDs
Figure 12. Product Picture of Biological Therapies
Figure 13. Product Picture of JAK-inhibitors
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Market Share by Type (2017-2028)
Figure 17. United States Rheumatoid Arthritis (RA) Drugs Market Share by Type in 2022 & 2028
Figure 18. United States Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 19. United States Rheumatoid Arthritis (RA) Drugs Market Share by Type (2017-2028)
Figure 20. Product Picture of Hospitals
Figure 21. Product Picture of Clinics
Figure 22. Product Picture of Others
Figure 23. Global Rheumatoid Arthritis (RA) Drugs Market Share by Application in 2022 & 2028
Figure 24. Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Rheumatoid Arthritis (RA) Drugs Market Share by Application (2017-2028)
Figure 26. United States Rheumatoid Arthritis (RA) Drugs Market Share by Application in 2022 & 2028
Figure 27. United States Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Rheumatoid Arthritis (RA) Drugs Market Share by Application (2017-2028)
Figure 29. North America Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. UAE Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 58. Roche Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 60. HEYL Chemisch-pharmazeutische Fabrik Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 61. Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 62. Amgen, Inc. Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 65. UCB Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 66. GSK Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 67. Sanofi Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 68. Abbott Laboratories Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 69. Teva Pharmaceutical Revenue Growth Rate in Rheumatoid Arthritis (RA) Drugs Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs